64 related articles for article (PubMed ID: 9920182)
21. SKF83959 is a novel triple reuptake inhibitor that elicits anti-depressant activity.
Fang X; Guo L; Jia J; Jin GZ; Zhao B; Zheng YY; Li JQ; Zhang A; Zhen XC
Acta Pharmacol Sin; 2013 Sep; 34(9):1149-55. PubMed ID: 23892272
[TBL] [Abstract][Full Text] [Related]
22. Neurobehavioral phenotyping of G(αq) knockout mice reveals impairments in motor functions and spatial working memory without changes in anxiety or behavioral despair.
Frederick AL; Saborido TP; Stanwood GD
Front Behav Neurosci; 2012; 6():29. PubMed ID: 22723772
[TBL] [Abstract][Full Text] [Related]
23. The dopamine d1-d2 receptor heteromer in striatal medium spiny neurons: evidence for a third distinct neuronal pathway in Basal Ganglia.
Perreault ML; Hasbi A; O'Dowd BF; George SR
Front Neuroanat; 2011; 5():31. PubMed ID: 21747759
[TBL] [Abstract][Full Text] [Related]
24. Dexamphetamine effects on separate constructs in the rubber hand illusion test.
Albrecht MA; Martin-Iverson MT; Price G; Lee J; Iyyalol R; Waters F
Psychopharmacology (Berl); 2011 Sep; 217(1):39-50. PubMed ID: 21431312
[TBL] [Abstract][Full Text] [Related]
25. Pharmacology of signaling induced by dopamine D(1)-like receptor activation.
Undieh AS
Pharmacol Ther; 2010 Oct; 128(1):37-60. PubMed ID: 20547182
[TBL] [Abstract][Full Text] [Related]
26. Activation of phosphatidylinositol-linked D1-like receptor modulates FGF-2 expression in astrocytes via IP3-dependent Ca2+ signaling.
Zhang X; Zhou Z; Wang D; Li A; Yin Y; Gu X; Ding F; Zhen X; Zhou J
J Neurosci; 2009 Jun; 29(24):7766-75. PubMed ID: 19535588
[TBL] [Abstract][Full Text] [Related]
27. Activation of phosphatidylinositol-linked novel D1 dopamine receptor contributes to the calcium mobilization in cultured rat prefrontal cortical astrocytes.
Liu J; Wang F; Huang C; Long LH; Wu WN; Cai F; Wang JH; Ma LQ; Chen JG
Cell Mol Neurobiol; 2009 May; 29(3):317-28. PubMed ID: 18975071
[TBL] [Abstract][Full Text] [Related]
28. Rotation and immediate-early gene expression in rats treated with the atypical D1 dopamine agonist SKF 83822.
Wirtshafter D
Pharmacol Biochem Behav; 2007 Mar; 86(3):505-10. PubMed ID: 17306871
[TBL] [Abstract][Full Text] [Related]
29. Behavioral effects of the R-(+)- and S-(-)-enantiomers of the dopamine D(1)-like partial receptor agonist SKF 83959 in monkeys.
Desai RI; Neumeyer JL; Paronis CA; Nguyen P; Bergman J
Eur J Pharmacol; 2007 Mar; 558(1-3):98-106. PubMed ID: 17207791
[TBL] [Abstract][Full Text] [Related]
30. Phenotypic studies on dopamine receptor subtype and associated signal transduction mutants: insights and challenges from 10 years at the psychopharmacology-molecular biology interface.
Waddington JL; O'Tuathaigh C; O'Sullivan G; Tomiyama K; Koshikawa N; Croke DT
Psychopharmacology (Berl); 2005 Oct; 181(4):611-38. PubMed ID: 16041535
[TBL] [Abstract][Full Text] [Related]
31. Attenuation of relapse to cocaine seeking by dopamine D1 receptor agonists and antagonists in non-human primates.
Khroyan TV; Platt DM; Rowlett JK; Spealman RD
Psychopharmacology (Berl); 2003 Jul; 168(1-2):124-131. PubMed ID: 12607074
[TBL] [Abstract][Full Text] [Related]
32. Aberrant behavioral effects of a dopamine D1 receptor antagonist and agonist in monkeys: evidence of uncharted dopamine D1 receptor actions.
Peacock L; Gerlach J
Biol Psychiatry; 2001 Oct; 50(7):501-9. PubMed ID: 11600103
[TBL] [Abstract][Full Text] [Related]
33. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
Wirtshafter D; Osborn CV
Eur J Pharmacol; 2005 Dec; 528(1-3):88-94. PubMed ID: 16324697
[TBL] [Abstract][Full Text] [Related]
34. Dopamine D1 receptor signaling: does GαQ-phospholipase C actually play a role?
Lee SM; Yang Y; Mailman RB
J Pharmacol Exp Ther; 2014 Oct; 351(1):9-17. PubMed ID: 25052835
[TBL] [Abstract][Full Text] [Related]
35. Dopamine receptor multiplicity: "D1-like'-"D2-like' interactions and " D1-like" receptors not linked to adenylate cyclase.
Waddington JL; Deveney AM
Biochem Soc Trans; 1996 Feb; 24(1):177-82. PubMed ID: 8674655
[No Abstract] [Full Text] [Related]
36. The alleged dopamine D1 receptor agonist SKF 83959 is a dopamine D1 receptor antagonist in primate cells and interacts with other receptors.
Andringa G; Drukarch B; Leysen JE; Cools AR; Stoof JC
Eur J Pharmacol; 1999 Jan; 364(1):33-41. PubMed ID: 9920182
[TBL] [Abstract][Full Text] [Related]
37. Selective dopamine antagonist pretreatment on the antiparkinsonian effects of benzazepine D1 dopamine agonists in rodent and primate models of Parkinson's disease--the differential effects of D1 dopamine antagonists in the primate.
Gnanalingham KK; Hunter AJ; Jenner P; Marsden CD
Psychopharmacology (Berl); 1995 Feb; 117(4):403-12. PubMed ID: 7604140
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
